---
title: "Incannex Healthcare aligns PSX-001 program with White House order, cites strong Phase 2 data and $70M cash"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283661455.md"
description: "Incannex Healthcare aligns its PSX-001 program with a White House Executive Order, highlighting strong Phase 2 data that shows a significant reduction in anxiety symptoms. The Phase 2 trial reported a 12.8-point reduction in HAM-A scores compared to 3.6 for placebo, with a 44% clinically meaningful response and 27% remission sustained for 11 weeks. The company has over $70 million in cash, no debt, and an active U.S. IND, positioning it well for advancement amid regulatory changes."
datetime: "2026-04-22T12:03:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283661455.md)
  - [en](https://longbridge.com/en/news/283661455.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283661455.md)
---

# Incannex Healthcare aligns PSX-001 program with White House order, cites strong Phase 2 data and $70M cash

**Incannex Healthcare supports White House Executive Order and says PSX-001 Phase 2 data and a favorable regulatory shift accelerate access to oral psilocybin for GAD.**

**Key Highlights:**

-   Company says PSX-001 Phase 2 showed 12.8‑point HAM‑A reduction vs 3.6 for placebo (p<0.0001), supporting efficacy.
-   Reported 44% clinically meaningful response (≥50% reduction) and 27% remission (HAM‑A ≤7) sustained through 11 weeks.
-   No serious adverse events and one discontinuation among 73 patients, indicating favorable tolerability in Phase 2.
-   Company cites active U.S. IND, over $70 million cash and no debt, positioning program to advance amid regulatory easing.

Original SEC Filing: Incannex Healthcare Inc. \[ IXHL \] - 8-K - Apr. 22, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [IXHL.US](https://longbridge.com/en/quote/IXHL.US.md)
- [PSIL.US](https://longbridge.com/en/quote/PSIL.US.md)

## Related News & Research

- [Trump's psychedelic drug order boosts investor interest with promise of faster reviews](https://longbridge.com/en/news/286750347.md)
- [SMC backs first-line metastatic bladder cancer combination after trial results](https://longbridge.com/en/news/286065296.md)
- [WHITE HOUSE POSTPONES AI EO SIGNING CEREMONY: AXIOS](https://longbridge.com/en/news/287246865.md)
- [If You Invested $100 In Phillips 66 Stock 5 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/286834498.md)
- [Phillips 66 Appoints Greg Hayes as Lead Independent Director | PSX Stock News](https://longbridge.com/en/news/286296547.md)